Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease

Alzheimer’s disease, a devastating neurodegenerative disorder, is characterized by progressive cognitive decline, primarily due to amyloid-beta protein deposition and tau protein phosphorylation. Effectively reducing the cytotoxicity of amyloid-beta42 aggregates and tau oligomers may help slow the p...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sha Sha, Lina Ren, Xiaona Xing, Wanshu Guo, Yan Wang, Ying Li, Yunpeng Cao, Le Qu
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2026-02-01
Serija:	Neural Regeneration Research
Teme:	alzheimer’s disease amyloid deposits amyloid-beta antibody cognitive dysfunction dementia immunotherapy oligomer preventive immunization tau hyperphosphorylation
Online dostop:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00846
Oznake:	Označite Brez oznak, prvi označite!